A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis

ClinicalTrials.gov ID: NCT06080789

Public ClinicalTrials.gov record NCT06080789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 19, 2026, 6:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Multi-Center, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 Administered by Endoscopic Ultrasound-Guided Peripancreatic Injection Plus Standard-of-Care Versus Standard-of-Care Only in Participants With Predicted Severe Acute Pancreatitis

Study identification

NCT ID: NCT06080789
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Panafina, Inc.; Industry
Enrollment: 36 participants

Conditions and interventions

Conditions

Acute Pancreatitis

Interventions

RABI-767 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 85 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 27, 2024
Primary completion: Oct 31, 2026
Completion: Oct 31, 2026
Last update posted: Apr 2, 2026

2024 – 2026

United States locations

U.S. sites: 11
U.S. states: 10
U.S. cities: 11

Facility	City	State	ZIP	Site status
University of Arkansas for Medical Sciences	Little Rock	Arkansas	72205	Recruiting
Keck Hospital of USC and LA County Hospital	Los Angeles	California	90033	Recruiting
University of Colorado Anschutz Medical Campus	Aurora	Colorado	80045	Recruiting
University of Florida Health	Gainesville	Florida	32608	Recruiting
Orlando Health	Orlando	Florida	32806	Recruiting
UI Health, University of Illinois Chicago Hospital Health Sciences System	Chicago	Illinois	60612	Recruiting
Indiana University Health University Hospital	Indianapolis	Indiana	46202	Withdrawn
Johns Hopkins Hospital	Baltimore	Maryland	21287	Recruiting
Henry Ford Hospital	Detroit	Michigan	48202	Recruiting
Dartmouth Hitchcock Medical Center	Lebanon	New Hampshire	03756	Recruiting
NYU Langone Medical Center	New York	New York	10016	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06080789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 2, 2026 · Synced May 19, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06080789 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →